View the Latest: Contraception
Filter
-
-
2024 Women’s Health Survey
FeatureThe 2024 KFF Women’s Health Survey (WHS) is the latest in a series of nationally representative surveys on women’s health conducted by KFF since 2001. The survey’s objective is to track and document women’s experiences and knowledge related to health and well-being.
-
DMPA Contraceptive Injection: Use and Coverage
Fact SheetThis factsheet provides an overview of the types of contraceptive injection, use, awareness, availability, and insurance coverage of the injection in the U.S.
-
The Right to Contraception: State and Federal Actions, Misinformation, and the Courts
Issue BriefThis issue brief explains how misinformation about contraceptives and how pregnancy is defined in state abortion bans may impact contraceptive access, and outlines the legal protections some states have established to affirm the right to obtain contraceptives.
-
Coverage of Sexual and Reproductive Health Services in Medicare
Issue BriefThis brief describes Medicare coverage of sexual and reproductive health services, including contraception, and compares that coverage with private insurance plans and Medicaid. These benefits are particularly relevant to nearly 1 million women of reproductive age (20-49) who are eligible for Medicare due to having a long-term disability.
-
Could the Comstock Act Be Used to Limit Abortion Access Nationwide?
News ReleaseIn a new brief, KFF examines how the Comstock Act, an 1873 anti-vice law banning the mailing of obscene matter and articles, could be used by an anti-abortion presidential administration to sharply restrict the availability of abortion nationwide. The Biden Administration’s Department of Justice has said the Comstock Act should not be interpreted literally with respect to abortion and has not enforced it. However, a future administration opposed to abortion rights could interpret the law…
-
3 Charts: The Cost and Coverage of Opill—the First FDA-approved Over-the-Counter Daily Oral Contraceptive Pill in the United States
News ReleaseThe first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores. Although the new over-the-counter pill could broaden access to contraceptive options in the United States, KFF research suggests consumers are likely to face some hurdles if they seek to have their plan cover the costs. For example, while federal policy requires most private health insurance…
-
Preventive Services Covered by Private Health Plans under the Affordable Care Act
Fact SheetNote: This content was updated on February 28, 2024 to incorporate new FAQs from CMS. Tables 1 and 2 were also updated to include updated recommendations. It has been more than ten years since the Affordable Care Act (ACA) required private insurance plans to cover recommended preventive services without any patient cost-sharing. Research has shown that evidence-based preventive services can save lives and improve health by identifying illnesses earlier, managing them more effectively, and treating…
-
Want to Learn About Women’s Health in your State? Check out KFF’s Updated Interactive Dashboard
News ReleaseKFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health. The dashboard provides instant access the most up-to-date state level indicators of women’s health in the U.S. Many of the indicators also provide national and state-level information for women of different racial and ethnic groups. Dashboard topics include: Abortion availability, coverage, and use by race/ethnicity. Maternal and infant mortality, preterm…
-
Year in Review: 10 Health Policy Issues for 2023
Fact SheetThis fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.